NUTX vs. AVGO
NUTX (Nutex Health Inc) and AVGO (Broadcom Inc.) are both stocks. NUTX operates in Health Information Services (Healthcare), while AVGO operates in Semiconductors (Technology). Over the past 3 years, NUTX returned 31.22%/yr vs 67.17%/yr for AVGO. At a 0.13 correlation, their price movements are largely independent.
Performance
NUTX vs. AVGO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NUTX achieves a -12.28% return, which is significantly lower than AVGO's 10.62% return.
NUTX
- 1D
- -1.78%
- 1M
- 14.33%
- YTD
- -12.28%
- 6M
- -21.90%
- 1Y
- 18.09%
- 3Y*
- 31.22%
- 5Y*
- —
- 10Y*
- —
AVGO
- 1D
- -0.91%
- 1M
- -10.14%
- YTD
- 10.62%
- 6M
- 6.58%
- 1Y
- 54.87%
- 3Y*
- 67.17%
- 5Y*
- 55.09%
- 10Y*
- 40.96%
NUTX vs. AVGO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
NUTX Nutex Health Inc | -12.28% | 419.47% | 17.37% | -90.53% | -81.82% |
AVGO Broadcom Inc. | 10.62% | 50.63% | 110.49% | 104.18% | -8.57% |
Correlation
The correlation between NUTX and AVGO is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Apr 4, 2022 | 0.13 |
Fundamentals
NUTX:
$19.08
AVGO:
$6.01
NUTX:
7.57
AVGO:
63.58
NUTX:
0.06
AVGO:
0.79
NUTX:
0.83
AVGO:
24.70
NUTX:
$879.95M
AVGO:
$75.47B
NUTX:
$417.67M
AVGO:
$50.53B
NUTX:
$275.94M
AVGO:
$41.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NUTX vs. AVGO — Risk / Return Rank
NUTX
AVGO
NUTX vs. AVGO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nutex Health Inc (NUTX) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NUTX | AVGO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.95 | ||
| Sortino ratioReturn per unit of downside risk | -0.77 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.22 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 0.29 | 1.77 | -1.48 |
| Martin ratioReturn relative to average drawdown | 0.50 | 4.11 | -3.61 |
Loading charts...
Drawdowns
NUTX vs. AVGO - Drawdown Comparison
The maximum NUTX drawdown since its inception was -99.93%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for NUTX and AVGO.
Loading charts...
Drawdown Indicators
| NUTX | AVGO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.93% | -48.30% | -51.63% |
Max Drawdown (1Y)Largest decline over 1 year | -54.32% | -28.67% | -25.65% |
Max Drawdown (3Y)Largest decline over 3 years | -94.36% | -41.15% | -53.21% |
Max Drawdown (5Y)Largest decline over 5 years | — | -41.15% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -48.30% | — |
Current DrawdownCurrent decline from peak | -97.59% | -20.66% | -76.93% |
Average DrawdownAverage peak-to-trough decline | -97.18% | -7.98% | -89.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.94% | 12.30% | +18.64% |
Volatility
NUTX vs. AVGO - Volatility Comparison
The current volatility for Nutex Health Inc (NUTX) is 17.20%, while Broadcom Inc. (AVGO) has a volatility of 20.53%. This indicates that NUTX experiences smaller price fluctuations and is considered to be less risky than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NUTX | AVGO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.20% | 20.53% | -3.33% |
Volatility (6M)Calculated over the trailing 6-month period | 63.60% | 35.04% | +28.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 94.82% | 45.57% | +49.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 191.90% | 43.39% | +148.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 191.90% | 39.52% | +152.38% |
Dividends
NUTX vs. AVGO - Dividend Comparison
NUTX has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.65%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AVGO Broadcom Inc. | 0.65% | 0.70% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% |
NUTX Nutex Health Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NUTX vs. AVGO - Financials Comparison
This section allows you to compare key financial metrics between Nutex Health Inc and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NUTX vs. AVGO - Profitability Comparison
NUTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nutex Health Inc reported a gross profit of 91.73M and revenue of 216.49M. Therefore, the gross margin over that period was 42.4%.
AVGO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported a gross profit of 14.92B and revenue of 22.19B. Therefore, the gross margin over that period was 67.2%.
NUTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nutex Health Inc reported an operating income of 81.27M and revenue of 216.49M, resulting in an operating margin of 37.5%.
AVGO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported an operating income of 10.87B and revenue of 22.19B, resulting in an operating margin of 49.0%.
NUTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nutex Health Inc reported a net income of 46.81M and revenue of 216.49M, resulting in a net margin of 21.6%.
AVGO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported a net income of 9.31B and revenue of 22.19B, resulting in a net margin of 42.0%.
Frequently Asked Questions
NUTX and AVGO have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVGO has higher volatility (20.53%) compared to NUTX (17.20%). In terms of maximum drawdown, NUTX dropped -99.93% vs AVGO's -48.30%.
AVGO currently has the higher Sharpe Ratio (1.11 vs 0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NUTX and AVGO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer